Levetiracetam Neuraxpharm

Levetiracetam, the active ingredient in Levetiracetam Neuraxpharm, is an anticonvulsant presented as an oral tablet for oral use. It treats various seizure types in patients with epilepsy and is prescribed for long‑term seizure control.

GNH USA supplies Levetiracetam Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide.

Levetiracetam is an antiepileptic medication used to control seizures by modulating neuronal excitability.

- Partial‑onset seizures: reduces the frequency of focal seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: decreases myoclonic jerks.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Headache - Nausea

Serious or Rare Side Effects: - Severe allergic reaction (e.g., anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Mood changes including depression or suicidal thoughts

Before initiating therapy, clinicians should consider several safety aspects.

- Renal function: assess and adjust dose in renal impairment. - Psychiatric history: monitor for mood changes or suicidal ideation. - Discontinuation: avoid abrupt cessation to prevent seizure worsening. - Pregnancy: use only if potential benefit outweighs risk. - Storage: Store at room temperature: keep in original container, protect from moisture.

Levetiracetam can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Carbamazepine: may decrease levetiracetam plasma levels. - Enzyme‑inducing antiepileptics (e.g., phenytoin, phenobarbital): reduce exposure. - Alcohol: can enhance central nervous system depression.

Moderate Interactions (Monitor Closely): - Antidepressants: may increase risk of behavioral changes. - Hormonal contraceptives: efficacy may be reduced. - Other antiepileptics: dose adjustments may be needed.